Breakout Discussions

Tuesday, March 3, 2020 • 2:00 - 3:00 pm • Exhibit Hall

These interactive discussion groups are open to all attendees, speakers, sponsors, and exhibitors. Participants choose a specific breakout discussion group to join. Each group has a moderator to ensure focused discussions around key issues within the topic. This format allows participants to meet potential collaborators, share examples from their work, vet ideas with peers, and be part of a group problem-solving endeavor. The discussions provide an informal exchange of ideas and are not meant to be a corporate or specific product discussion. The list of topics will span Tri-Con’s three core conferences: Conference 1: Precision Health, Conference 2: Digital Health, and Conference 3: Bio-IT World Conference & Expo WEST. Visit here for finer details on our core conferences. Please visit this page during the August-September time frame for further developments.

Former discussion topics have included:

  • Data-Driven Diagnostics
  • Payers and Regulators: Recent Developments
  • Whole Genome Sequencing as a Diagnostic Test
  • Utilizing Whole Slide Imaging and Image Analysis in the Histology Laboratory for Quality Assurance and Improvement
  • Digital Pathology Interoperability Priorities
  • Digital Pathology Applications for Predictive Biomarkers
  • Practical Considerations when Implementing Digital Pathology
  • Pathology AI: The Promise and the Problems
  • The Future of Vertical and Lateral Flow Diagnostic Devices
  • AI and ML in Pathology Practice
  • Home-Based Diagnostic Testing
  • The Future of Pharmacy-Based Point-of-Care Testing
  • Overcoming Barriers to More Accurate and Scalable Genetic Variant Classification
  • Best Practices for Clinical Validation of Bioinformatics Pipeline
  • Bioinformatics Quality at Clinical Scale
  • Digital Health Platforms Incorporating Diverse Data Sources
  • Around the Globe Strategies for Diagnostics and Clinical Biomarkers
  • Evolutionary Biomarkers: New Ways to Work with Pharma Companies
  • Genomic Diagnostics in Solid Tumors: Current Practices and Future Developments
  • Hidden Challenges in Building and Analyzing Biological Networks
  • Implementing Molecular Tumor Board in the Community Setting
  • Roadblocks to Functional Precision Medicine
  • Parallel Analysis of Circulating Biomarkers in Immunotherapy
  • Clinical Utility and Impact of Liquid Biopsy
  • The Importance and Challenge in CTC Culture
  • Deploying Bioengineered 3D Tumor Models into Clinical Practice and the Pharmaceutical Pipeline
  • Isolation and Analysis of CTCs
  • Precision Medicine in IO
  • Emerging Technologies for IO Biomarkers
  • Target Identification from -Omic Data
  • Machine Learning for Data Driven Drug Discovery
  • Practical Machine Learning in Industry
  • Exploring the Power of Quantum Computing for Science and Discovery
  • Diversity and Inclusion in Bio-IT
  • What Can Cloud Do for My Organization?
Choose your language
Japanese




Premier Sponsors

Discovery-Life-Sciences

NeoGenomics

xiMedicaDx